COVID-19: Antidepressant reduces risk of hospitalization and death
A clinical trial has found that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, significantly reduces the chances of hospitalization …
Home ยป
A clinical trial has found that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, significantly reduces the chances of hospitalization …